chr1-5909193-G-A
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_015102.5(NPHP4):c.1462C>T(p.Arg488Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000048 in 1,604,058 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015102.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHP4 | NM_015102.5 | c.1462C>T | p.Arg488Ter | stop_gained | 12/30 | ENST00000378156.9 | NP_055917.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHP4 | ENST00000378156.9 | c.1462C>T | p.Arg488Ter | stop_gained | 12/30 | 1 | NM_015102.5 | ENSP00000367398 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000609 AC: 14AN: 230052Hom.: 1 AF XY: 0.0000802 AC XY: 10AN XY: 124644
GnomAD4 exome AF: 0.0000441 AC: 64AN: 1451934Hom.: 1 Cov.: 32 AF XY: 0.0000402 AC XY: 29AN XY: 720942
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74310
ClinVar
Submissions by phenotype
Nephronophthisis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 24, 2023 | This sequence change creates a premature translational stop signal (p.Arg488*) in the NPHP4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP4 are known to be pathogenic (PMID: 12205563, 23559409). This variant is present in population databases (rs778043242, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This premature translational stop signal has been observed in individual(s) with nephronophthisis (PMID: 15776426). ClinVar contains an entry for this variant (Variation ID: 297820). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Nephronophthisis 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Precision Medicine Center, Zhengzhou University | Dec 01, 2023 | PVS1,PM2_p,PM3 - |
NPHP4-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The NPHP4 c.1462C>T (p.Arg488Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Arg488Ter variant has been reported in a single study in which it was found in a homozygous state in one individual with nephronophthisis (Hoefele et al. 2005). The p.Arg488Ter variant was absent from at least 86 controls and is reported at a frequency of 0.00020 in the European (non-Finnish) population of the Exome Aggregation Consortium. The evidence for this variant is limited. Based on the potential impact of stop-gained variants and the limited evidence from the literature, the p.Arg488Ter variant is classified a variant of unknown significance but suspicious for pathogenicity for NPHP4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 13, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at